Knyazev P - Search Results

1

UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines.

Singh B, Schneider M, Knyazev P, Ullrich A. Singh B, et al. Among authors: knyazev p. Int J Cancer. 2009 Feb 1;124(3):531-9. doi: 10.1002/ijc.23974. Int J Cancer. 2009. PMID: 19003995

2

Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation.

Roidl A, Berger HJ, Kumar S, Bange J, Knyazev P, Ullrich A. Roidl A, et al. Among authors: knyazev p. Clin Cancer Res. 2009 Mar 15;15(6):2058-66. doi: 10.1158/1078-0432.CCR-08-0890. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240166

3

Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.

Ruhe JE, Streit S, Hart S, Wong CH, Specht K, Knyazev P, Knyazeva T, Tay LS, Loo HL, Foo P, Wong W, Pok S, Lim SJ, Ong H, Luo M, Ho HK, Peng K, Lee TC, Bezler M, Mann C, Gaertner S, Hoefler H, Iacobelli S, Peter S, Tay A, Brenner S, Venkatesh B, Ullrich A. Ruhe JE, et al. Among authors: knyazev p. Cancer Res. 2007 Dec 1;67(23):11368-76. doi: 10.1158/0008-5472.CAN-07-2703. Cancer Res. 2007. PMID: 18056464

4

PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.

Gärtner S, Gunesch A, Knyazeva T, Wolf P, Högel B, Eiermann W, Ullrich A, Knyazev P, Ataseven B. Gärtner S, et al. Among authors: knyazev p. PLoS One. 2014 Jan 7;9(1):e84472. doi: 10.1371/journal.pone.0084472. eCollection 2014. PLoS One. 2014. PMID: 24409301 Free PMC article.

5

HER3 is a determinant for poor prognosis in melanoma.

Reschke M, Mihic-Probst D, van der Horst EH, Knyazev P, Wild PJ, Hutterer M, Meyer S, Dummer R, Moch H, Ullrich A. Reschke M, et al. Among authors: knyazev p. Clin Cancer Res. 2008 Aug 15;14(16):5188-97. doi: 10.1158/1078-0432.CCR-08-0186. Clin Cancer Res. 2008. PMID: 18698037

6

Identification of MMP-15 as an anti-apoptotic factor in cancer cells.

Abraham R, Schäfer J, Rothe M, Bange J, Knyazev P, Ullrich A. Abraham R, et al. Among authors: knyazev p. J Biol Chem. 2005 Oct 7;280(40):34123-32. doi: 10.1074/jbc.M508155200. Epub 2005 Aug 9. J Biol Chem. 2005. PMID: 16093241

7

FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression.

Stadler CR, Knyazev P, Bange J, Ullrich A. Stadler CR, et al. Among authors: knyazev p. Cell Signal. 2006 Jun;18(6):783-94. doi: 10.1016/j.cellsig.2005.07.002. Epub 2005 Aug 18. Cell Signal. 2006. PMID: 16109476

8

Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells.

Oak PS, Kopp F, Thakur C, Ellwart JW, Rapp UR, Ullrich A, Wagner E, Knyazev P, Roidl A. Oak PS, et al. Among authors: knyazev p. Int J Cancer. 2012 Dec 15;131(12):2808-19. doi: 10.1002/ijc.27595. Epub 2012 May 21. Int J Cancer. 2012. PMID: 22511343

9

Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status.

Xiao Z, Sperl B, Ullrich A, Knyazev P. Xiao Z, et al. Among authors: knyazev p. Oncotarget. 2014 Dec 30;5(24):12877-90. doi: 10.18632/oncotarget.2657. Oncotarget. 2014. PMID: 25375092 Free PMC article.

10

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.

Sommer AK, Hermawan A, Mickler FM, Ljepoja B, Knyazev P, Bräuchle C, Ullrich A, Wagner E, Roidl A. Sommer AK, et al. Among authors: knyazev p. Oncotarget. 2016 Aug 2;7(31):50461-50476. doi: 10.18632/oncotarget.10459. Oncotarget. 2016. PMID: 27409163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results